Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,942 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Embracing life after prostate cancer. A male perspective on treatment and rehabilitation.
Dieperink KB, Wagner L, Hansen S, Hansen O. Dieperink KB, et al. Among authors: hansen s, hansen o. Eur J Cancer Care (Engl). 2013 Jul;22(4):549-58. doi: 10.1111/ecc.12061. Epub 2013 Mar 21. Eur J Cancer Care (Engl). 2013. PMID: 23517147
The effects of multidisciplinary rehabilitation: RePCa-a randomised study among primary prostate cancer patients.
Dieperink KB, Johansen C, Hansen S, Wagner L, Andersen KK, Minet LR, Hansen O. Dieperink KB, et al. Among authors: hansen s, hansen o. Br J Cancer. 2013 Dec 10;109(12):3005-13. doi: 10.1038/bjc.2013.679. Epub 2013 Oct 29. Br J Cancer. 2013. PMID: 24169342 Free PMC article. Clinical Trial.
Independent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patients.
Hansen S, Overgaard J, Rose C, Knoop A, Laenkholm AV, Andersen J, Sørensen FB, Andreasen PA. Hansen S, et al. Br J Cancer. 2003 Jan 13;88(1):102-8. doi: 10.1038/sj.bjc.6600662. Br J Cancer. 2003. PMID: 12556967 Free PMC article.
Vascular grading of angiogenesis: prognostic significance in breast cancer.
Hansen S, Grabau DA, Sørensen FB, Bak M, Vach W, Rose C. Hansen S, et al. Br J Cancer. 2000 Jan;82(2):339-47. doi: 10.1054/bjoc.1999.0924. Br J Cancer. 2000. PMID: 10646886 Free PMC article.
A woman's build and the risk of breast cancer.
Cold S, Hansen S, Overvad K, Rose C. Cold S, et al. Among authors: hansen s. Eur J Cancer. 1998 Jul;34(8):1163-74. doi: 10.1016/s0959-8049(97)10167-8. Eur J Cancer. 1998. PMID: 9849474 Review.
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
Knoop A, Andreasen PA, Andersen JA, Hansen S, Laenkholm AV, Simonsen AC, Andersen J, Overgaard J, Rose C. Knoop A, et al. Among authors: hansen s. Br J Cancer. 1998 Mar;77(6):932-40. doi: 10.1038/bjc.1998.154. Br J Cancer. 1998. PMID: 9528837 Free PMC article.
Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy.
Hagen C, Schroeder HD, Hansen S, Hagen C, Andersen M. Hagen C, et al. Among authors: hansen s. Eur J Endocrinol. 2009 Oct;161(4):631-7. doi: 10.1530/EJE-09-0389. Epub 2009 Aug 4. Eur J Endocrinol. 2009. PMID: 19654234
Estimates of the sources of variation (variance components) of bioelectric impedance and anthropometric measurements in an epidemiological case-control study of breast cancer.
Hansen S, Cold S, Petersen PH, Rose C. Hansen S, et al. Eur J Clin Nutr. 1997 Nov;51(11):764-70. doi: 10.1038/sj.ejcn.1600485. Eur J Clin Nutr. 1997. PMID: 9368811
The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients.
Hansen S, Grabau DA, Sørensen FB, Bak M, Vach W, Rose C. Hansen S, et al. Clin Cancer Res. 2000 Jan;6(1):139-46. Clin Cancer Res. 2000. PMID: 10656442
Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
Hansen S, Sørensen FB, Vach W, Grabau DA, Bak M, Rose C. Hansen S, et al. Histopathology. 2004 May;44(5):428-36. doi: 10.1111/j.1365-2559.2004.01848.x. Histopathology. 2004. PMID: 15139990
2,942 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback